Evolent Health, Inc. EVH Reportable segment — Depreciation and amortization expenses
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Evolent Health, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DepreciationAndAmortization.
The official record: Evolent Health, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Evolent Health, Inc.'s reportable segment — depreciation and amortization expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Evolent Health, Inc.'s reportable segment — depreciation and amortization expenses?
- Evolent Health, Inc. (EVH) reported reportable segment — depreciation and amortization expenses of $21.56M in Q1 2026.
- How has Evolent Health, Inc.'s reportable segment — depreciation and amortization expenses changed year-over-year?
- Evolent Health, Inc.'s reportable segment — depreciation and amortization expenses decreased by 10.4% year-over-year, from $24.06M to $21.56M.
- What is the long-term trend for Evolent Health, Inc.'s reportable segment — depreciation and amortization expenses?
- Over 3 years (2022 to 2025), Evolent Health, Inc.'s reportable segment — depreciation and amortization expenses has grown at a 19.9% compound annual growth rate (CAGR), from $67.2M to $115.85M.
- What does reportable segment — depreciation and amortization expenses mean?
- This reflects the non-cash allocation of the cost of tangible and intangible assets over their useful lives within the segment. It is a critical component for understanding the capital intensity and the ongoing investment required to support the segment's technology and service platforms.